Please login to the form below

Not currently logged in
Email:
Password:

Awards recognise hepatitis C care in UK

First QiC Hepatitis C takes place at BASL conference
QiC Hepatitis C NHS Tayside

NHS Tayside won Best treatment pathway initiative at QiC Hepatitis C

Healthcare professionals working to improve care for hepatitis C patients in the UK were honoured last week at the first Quality in Care (QiC) Hepatitis C awards.

Held September 16 at the British Association for the Study of the Liver (BASL) conference in Gateshead QiC Hepatitis C celebrated the work of eight projects working to improve hepatitis C prevention, diagnosis & testing, treatment pathways and patient support in the UK.

Winners included NHS Tayside for its work providing access to hepatitis C treatment for people who inject drugs and Dundee CHP for its work to improve outcomes for patients with blood borne virus in Dundee.

QiC Hepatitis C Dundee CHP 

Dundee CHP won Best diagnosis & testing programme at QiC Hepatitis C 2014

Comments from judges on the NHS Tayside project included: “It is a cost-effective initiative with a patient-centred approach providing persuasive evidence that people who inject drugs can have similar or better treatment outcomes than people who do not inject drugs - much needed in the face of widespread resistance to treating this group of patients.”

Of the Dundee CHP project, judges said: “Raising awareness with GPs is vital and this project is delivering – impressive as GPs can so often be resistant.”

High commendations went to Dorset Viral Hepatitis Service and the Addaction programme in Cornwall.

Case studies of the projects will be presented on QiC Connect as part of the programme's efforts to share good practice in hepatitis C across the country.

The QiC Hepatitis C programme is funded by Bristol-Myers Squibb and Gilead and supported by BASL, British Liver Trust, The Hepatitis C Trust and Liver4Life.

Quality in Care is a series of programmes aimed at recognising quality and productivity in key therapy areas. Other QiC programmes include QiC Oncology, QiC Diabetes and QiC Anticoagulation.

Article by
Thomas Meek

26th September 2014

From: Healthcare

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Graphite

Graphite is a digital agency which partners with globally respected pharma and healthcare organisations to create powerful digital experiences. We...

Latest intelligence

PME-MAY21-Cover
Avoiding A Series of Unfortunate Events: launch lessons from lockdown
Chris Ross takes a novel look at launch excellence through the lens of COVID-19 and explores how pharma’s launch leaders are rewriting the story...
6 reasons patients drop out of clinical trials and 6 ways to fix it
If you’ve successfully recruited patients for your clinical trial, but one by one, they begin to drop out, then this information could be for you....
Sharing patient stories for World Pulmonary Hypertension Day
For World Pulmonary Hypertension Day and we’re here to help raise awareness of pulmonary hypertension (PH) - a frequently under and misdiagnosed condition. Created in collaboration with the PH patient...